Harvoni Alternatives Compared
| Harvoni (ledipasvir / sofosbuvir) | Ribavirin | Sovaldi (sofosbuvir) |
|
|---|
| Harvoni (ledipasvir / sofosbuvir) | Ribavirin | Sovaldi (sofosbuvir) |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Harvoni is a combination tablet containing ledipasvir and sofosbuvir. It may be used to treat certain genotypes of the hepatitis C virus in adults and children over the age of three. It is usually... View more |
Prescription only
Prescribed for RSV, Hepatitis C. Ribavirin may also be used for purposes not listed in this medication guide. |
Prescription only
Sovaldi may be used to treat certain genotypes of the hepatitis C virus in adults and children over the age of three. It must be given in combination with other treatments and cannot be used alone to... View more |
Related suggestions |
|||||||
| More about Harvoni (ledipasvir / sofosbuvir) | More about Ribavirin | More about Sovaldi (sofosbuvir) | ||||||||
| Ratings & Reviews | ||||||||||
|
Harvoni has an average rating of 8.6 out of 10 from a total of 403 ratings on Drugs.com. 81% of reviewers reported a positive effect, while 10% reported a negative effect. |
Ribavirin has an average rating of 5.1 out of 10 from a total of 10 ratings on Drugs.com. 44% of reviewers reported a positive effect, while 44% reported a negative effect. |
Sovaldi has an average rating of 7.7 out of 10 from a total of 47 ratings on Drugs.com. 71% of reviewers reported a positive effect, while 14% reported a negative effect. |
||||||||
| Drug Class | ||||||||||
| Side Effects | ||||||||||
| Generic Availability | ||||||||||
|
Lower cost generic |
||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Ribavirin prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
| Dosage Forms Available | ||||||||||
|
|
|
||||||||
| Brand Names | ||||||||||
|
N/A |
Rebetol, RibaTab, Virazole |
N/A |
||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||
|
47 hours |
960 hours |
27 hours |
||||||||
| CSA Schedule ** View glossary of terms | ||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | ||||||||||
|
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
Category B
No proven risk in humans
Category X
Not for use in pregnancy
In Combination With Ribavirin Or Peginterferon Alfa/Ribavirin See the full pregnancy warnings document. |
||||||||
| Drug Interactions | ||||||||||
|
A total of 176 drugs are known to interact with Harvoni:
|
A total of 18 drugs are known to interact with Ribavirin:
|
A total of 83 drugs are known to interact with Sovaldi:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
| Disease Interactions | ||||||||||
| First Approval Date | ||||||||||
|
October 10, 2014 |
June 03, 1998 |
December 06, 2013 |
||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||
|
N/A |
N/A |
N/A |
||||||||
| More Information | ||||||||||
| Patient resources | ||||||||||
| Professional Resources | ||||||||||
| Related Treatment Guide | ||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.